학술논문

The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy
Document Type
Article
Source
In: Human Vaccines and Immunotherapeutics. (Human Vaccines and Immunotherapeutics, 2023, 19(3))
Subject
Language
English
ISSN
2164554X
21645515